Sorafenib combined with transcatheter arterial chemoembolization and radiofrequency ablation in the treatment of postoperative recurrence of hepatocellular carcinoma

Authors
Category Primary study
JournalChinese Journal of Clinical Research
Year 2026
This article has no abstract
Epistemonikos ID: 3e6a0440e1fff31ab0d92adc5ff6652a8b369424
First added on: Sep 08, 2026